Cost Effectiveness of Pharmacogenetic Testing for Drugs with Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines: A Systematic Review

The objective of this study was to evaluate the evidence on cost‐effectiveness of pharmacogenetic (PGx)–guided treatment for drugs with Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines. A systematic review was conducted using multiple biomedical literature databases from incepti...

Descripción completa

Detalles Bibliográficos
Autores principales: Morris, Sarah A., Alsaidi, Ashraf T., Verbyla, Allison, Cruz, Adilen, Macfarlane, Casey, Bauer, Joseph, Patel, Jai N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828439/
https://www.ncbi.nlm.nih.gov/pubmed/36149409
http://dx.doi.org/10.1002/cpt.2754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828439/
https://www.ncbi.nlm.nih.gov/pubmed/36149409
http://dx.doi.org/10.1002/cpt.2754

Ejemplares similares